Long-term Stock Picks - New Portfolio

TJ Lawless

Long-term Stock Picks
Individual Investor
Ranked #392,435 out of 766,001 TipRanks' Investors
Success Rate
39%
168 out of 433
profitable transactions
Average Return
15.93%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 10.40%
6-Month Return▲ 6.69%
12-Month Return▲ 42.17%
YTD Return▲ 11.77%
Total Return▲ 20.03%

Best Trade

Opened at
Closed at-
Gain▲ 2390.18%

Bio

Biotech companies with great long-term growth prospects

Performance

25.72%0-25.72%
▼ 12.40%
▼ 4.03%
▼ 11.81%
Apr 2024
▲ 11.46%
▲ 5.06%
▼ 0.58%
May 2024
▼ 2.25%
▲ 3.53%
▼ 7.22%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 16.91%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 4.94%
Aug 2024
▲ 7.82%
▲ 2.10%
▲ 0.50%
Sep 2024
▲ 6.02%
▼ 0.89%
▼ 2.05%
Oct 2024
▲ 5.59%
▲ 5.20%
▲ 6.38%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 11.81%
▲ 11.46%▲ 5.06%▼ 0.58%
▼ 2.25%▲ 3.53%▼ 7.22%
▲ 25.72%▲ 1.21%▲ 16.91%
▼ 4.22%▲ 2.34%▼ 4.94%
▲ 7.82%▲ 2.10%▲ 0.50%
▲ 6.02%▼ 0.89%▼ 2.05%
▲ 5.59%▲ 5.20%▲ 6.38%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Osisko Mining
▲ 13.63%
2
Close
Oct 29, 2024
G1 Therapeutics
▼ 21.98%
5
Close
Sep 17, 2024
Deciphera Pharmaceuticals
▲ 39.68%
3
Close
Jun 10, 2024
Gamida Cell
▼ 99.46%
3
Close
May 24, 2024
Amyris
▼ 99.67%
3
Close
May 07, 2024
Viking Therapeutics
0.53%
▲ 1,174.93%
5
Buy
Apr 18, 2024
BHP Group
0.21%
▼ 2.16%
1
Open
Apr 18, 2024
NovoCure
0.4%
▲ 312.30%
4
Open
Apr 05, 2024
Inspire Medical Systems
2.28%
▼ 11.79%
1
Open
Apr 05, 2024
Vir Biotechnology
0.52%
▼ 55.61%
4
Buy
Mar 29, 2024
Danaher
10.44%
▲ 40.93%
7
Buy
Mar 29, 2024
Denali Therapeutics
1.94%
▲ 6.73%
4
Buy
Mar 29, 2024
Altimmune
▲ 142.73%
9
Close
Mar 20, 2024
Exelixis
▲ 39.75%
8
Close
Mar 20, 2024
Axsome Therapeutics
▲ 27.21%
6
Close
Mar 20, 2024
Limoneira Co
▲ 14.07%
2
Close
Mar 20, 2024
Capri Holdings
▲ 5.00%
3
Close
Mar 20, 2024
The Chefs' Warehouse
▲ 7.80%
3
Close
Mar 20, 2024
Qualcomm
▲ 38.37%
2
Close
Mar 20, 2024
Annexon Biosciences
▲ 5.18%
2
Close
Mar 20, 2024